Cara L Frankenfeld1,2, Timothy F Leslie3, Nirup M Menon4. 1. Global and Community Health, George Mason University, 4400 University Drive MS 5B7, Fairfax, VA, 22030, USA. cfranken@gmu.edu. 2. Master of Public Health Program, University of Puget Sound, 1500 N Warner St, Tacoma, WA, 98416, USA. cfranken@gmu.edu. 3. Geography and Geoinformation Science, George Mason University, Fairfax, VA, USA. 4. School of Business, George Mason University, Fairfax, VA, USA.
Abstract
PURPOSE: To evaluate time-to-treatment and survival time in colorectal cancer (CRC) patients who presumptively were not diagnosed in a hospital. METHODS: Colorectal tumor-level data from Georgia Cancer Registry (GCR) was merged with American Hospital Association data for 2010-2015 using hospital identification number. Patients with tumors lacking a diagnosis hospital in the GCR were classified as presumptive non-hospital diagnosis (PNHD). Cox proportional hazard models were used to model PNHD and time-to-treatment and time-to-death following cancer diagnosis, stratified by race and controlling for personal and tumor characteristics. RESULTS: PNHD (n = 6,885, 29.6%) was associated with a lower likelihood of treatment at a given point in time (i.e., longer time-to-treatment), but did not differ for Black (HR = 0.77, 95% CI: 0.73, 0.82) and White (HR = 0.73, 95% CI: 0.71, 0.76) patients. Time-to-death was longer (i.e., better survival) with PNHD, which also did not differ for Black (HR = 0.70, 95% CI: 0.64, 0.76) and White (HR = 0.71, 95% CI: 0.67, 0.75) patients. These results were not explained by confounding factors or differences in tumor stage at diagnosis. CONCLUSIONS: These observations warrant further research to understand whether there are potentially modifiable factors associated with the diagnosing location that can be used to benefit patient treatment trajectory and survival.
PURPOSE: To evaluate time-to-treatment and survival time in colorectal cancer (CRC) patients who presumptively were not diagnosed in a hospital. METHODS:Colorectal tumor-level data from Georgia Cancer Registry (GCR) was merged with American Hospital Association data for 2010-2015 using hospital identification number. Patients with tumors lacking a diagnosis hospital in the GCR were classified as presumptive non-hospital diagnosis (PNHD). Cox proportional hazard models were used to model PNHD and time-to-treatment and time-to-death following cancer diagnosis, stratified by race and controlling for personal and tumor characteristics. RESULTS: PNHD (n = 6,885, 29.6%) was associated with a lower likelihood of treatment at a given point in time (i.e., longer time-to-treatment), but did not differ for Black (HR = 0.77, 95% CI: 0.73, 0.82) and White (HR = 0.73, 95% CI: 0.71, 0.76) patients. Time-to-death was longer (i.e., better survival) with PNHD, which also did not differ for Black (HR = 0.70, 95% CI: 0.64, 0.76) and White (HR = 0.71, 95% CI: 0.67, 0.75) patients. These results were not explained by confounding factors or differences in tumor stage at diagnosis. CONCLUSIONS: These observations warrant further research to understand whether there are potentially modifiable factors associated with the diagnosing location that can be used to benefit patient treatment trajectory and survival.
Authors: H Singh; C De Coster; E Shu; K Fradette; S Latosinsky; M Pitz; M Cheang; D Turner Journal: Can J Gastroenterol Date: 2010-01 Impact factor: 3.522
Authors: Fabian Grass; Kevin T Behm; Emilie Duchalais; Jacopo Crippa; Grant M Spears; William S Harmsen; Martin Hübner; Kellie L Mathis; Scott R Kelley; John H Pemberton; Eric J Dozois; David W Larson Journal: Eur J Surg Oncol Date: 2019-11-28 Impact factor: 4.424
Authors: Jeffrey J Tomaszewski; Elizabeth Handorf; Anthony T Corcoran; Yu-Ning Wong; Reza Mehrazin; Justin E Bekelman; Daniel Canter; Alexander Kutikov; David Y T Chen; Robert G Uzzo; Marc C Smaldone Journal: J Urol Date: 2014-05-14 Impact factor: 7.450
Authors: David Roder; Christos Stelios Karapetis; Ian Olver; Dorothy Keefe; Robert Padbury; James Moore; Rohit Joshi; David Wattchow; Dan L Worthley; Caroline Louise Miller; Carol Holden; Elizabeth Buckley; Kate Powell; Dianne Buranyi-Trevarton; Kellie Fusco; Timothy Price Journal: BMJ Open Date: 2019-09-30 Impact factor: 2.692